Befejeződött1. fázis
Investigation of pharmacokinetics, safety and tolerability of a single subcutaneous dose of NNC0487-0111 in participants with various degrees of renal impairment and normal renal function.
Key facts
- Where
- Berlin, NémetországSee the site
- Phase
- 1. fázis
Where in Németország
- Charite Research Organisation GmbHBerlin, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Novo Nordisk A/S
- Trial code
- EU 2023-509961-19-00
- Record updated
- 2025. június 12.